These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 12663502)
1. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis. Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502 [TBL] [Abstract][Full Text] [Related]
2. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells. Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389 [TBL] [Abstract][Full Text] [Related]
3. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells. Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395 [TBL] [Abstract][Full Text] [Related]
4. Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Anna CH; Iida M; Sills RC; Devereux TR Toxicol Appl Pharmacol; 2003 Jul; 190(2):135-45. PubMed ID: 12878043 [TBL] [Abstract][Full Text] [Related]
5. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity. Ramljak D; Calvert RJ; Wiesenfeld PW; Diwan BA; Catipovic B; Marasas WF; Victor TC; Anderson LM; Gelderblom WC Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956 [TBL] [Abstract][Full Text] [Related]
6. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma. Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019 [TBL] [Abstract][Full Text] [Related]
7. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813 [TBL] [Abstract][Full Text] [Related]
8. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952 [TBL] [Abstract][Full Text] [Related]
9. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes. Cui J; Zhou X; Liu Y; Tang Z; Romeih M J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase. Xu XM; Zhou YQ; Wang MH J Biol Chem; 2005 Jul; 280(26):25087-94. PubMed ID: 15878878 [TBL] [Abstract][Full Text] [Related]
11. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056 [TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. Monick MM; Carter AB; Robeff PK; Flaherty DM; Peterson MW; Hunninghake GW J Immunol; 2001 Apr; 166(7):4713-20. PubMed ID: 11254732 [TBL] [Abstract][Full Text] [Related]
13. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953 [TBL] [Abstract][Full Text] [Related]
15. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma. Cui J; Zhou X; Liu Y; Tang Z; Romeih M Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479 [TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622 [TBL] [Abstract][Full Text] [Related]
17. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416 [TBL] [Abstract][Full Text] [Related]
18. Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells. Gines S; Ivanova E; Seong IS; Saura CA; MacDonald ME J Biol Chem; 2003 Dec; 278(50):50514-22. PubMed ID: 14522959 [TBL] [Abstract][Full Text] [Related]
19. beta-catenin signaling and regulation of cyclin D1 promoter in NRK-49F cells transformed by down-regulation of the tumor suppressor lysyl oxidase. Giampuzzi M; Oleggini R; Albanese C; Pestell R; Di Donato A Biochim Biophys Acta; 2005 Sep; 1745(3):370-81. PubMed ID: 15946752 [TBL] [Abstract][Full Text] [Related]
20. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]